πŸ‡ΊπŸ‡Έ FDA
Patent

US 9744159

Methods of treatment Rett syndrome

granted A61KA61K31/437A61K9/0019

Quick answer

US patent 9744159 (Methods of treatment Rett syndrome) held by OVID THERAPEUTICS INC. expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OVID THERAPEUTICS INC.
Grant date
Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/437, A61K9/0019, A61K9/0053, A61K9/7023